Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase I study of AVB-S6-500 demonstrates proof of mechanism

May 11, 2018

FDA identifies deficiencies during NDA review of Methylene Blue MMX

May 11, 2018

Lilly to acquire ARMO BioSciences

May 11, 2018

Phosphodiesterase PDE4 inhibitors patented byTakeda

May 11, 2018

MFN2 agonist restores mitochondrial trafficking in models of Charcot-Marie-Tooth disease type 2A

May 11, 2018

Pharmasum Therapeutics identifies novel DYRK inhibitors

May 11, 2018

Novel PTP-2C inhibitors discovered at DE Shaw Research, Relay Therapeutics

May 11, 2018

Patient recruitment ongoing in phase I trial of PF-06821497

May 11, 2018

Prelude Therapeutics discovers PRMT5 inhibitors

May 11, 2018

Novel P2X purinoceptor 7 antagonists discovered at Shionogi

May 11, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...